# Improving Function, Quality of Life, Glycemia in Diabetics With Dementia

> **NCT00792662** · PHASE4 · WITHDRAWN · sponsor: **University of Nebraska**

## Conditions studied

- Diabetes Mellitus
- Alzheimer's Disease
- Apathy
- Dementia

## Interventions

- **DRUG:** Methylphenidate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00792662
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-11-18
- **Primary completion:** 2011-12-20
- **Final completion:** 2011-12-20
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No Subjects enrolled
- **Last updated:** 2024-09-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00792662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00792662, "Improving Function, Quality of Life, Glycemia in Diabetics With Dementia". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00792662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*